No connection

Search Results

Regulation Score 68 Bullish

US Executive Order Triggers Rally in Psychedelic Therapy Equities

Apr 20, 2026 12:43 UTC
Compass Pathways Plc, AtaiBeckley Inc., Definium Therapeutics, Inc., GH Research PLC
Short term

Shares of psychedelic-focused biotech firms surged in premarket trading following a presidential executive order. The directive aims to accelerate research and expand access to psychedelic-based treatments.

  • President Trump signed an executive order to expedite psychedelic research
  • Compass Pathways Plc shares spiked up to 39%
  • AtaiBeckley Inc. shares surged 32%
  • Definium Therapeutics and GH Research saw gains of 27% and 20% respectively
  • The order aims to reduce barriers to access and clinical study

The US psychedelic therapy sector experienced a sharp rally on Monday morning after President Donald Trump signed an executive order designed to streamline research and facilitate broader access to these treatments. The move signals a potential shift in federal policy toward the medical use of psychedelics, reducing regulatory hurdles for companies developing therapies for mental health and other neurological conditions. This regulatory easing is expected to lower the barrier for clinical trials and commercialization, providing a significant tailwind for specialized biotech firms. Market reaction was immediate and pronounced in premarket trading. Compass Pathways Plc saw the strongest gains, with shares spiking as much as 39%. AtaiBeckley Inc. followed with a 32% surge, while Definium Therapeutics, Inc. and GH Research PLC rose by 27% and 20%, respectively. Investors are reacting to the prospect of a faster path to FDA approval and wider patient eligibility, which could fundamentally alter the revenue trajectories for companies in the psychedelic medicine space.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 58

BIS Warns of Systemic Risks as Global Stablecoin Regulation Stalls

Apr 20, 14:31

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile